Mazor Robotics

Mazor Robotics
Name	Mazor Robotics
Industry	Medical robotics
Founded	2001
Headquarters	Caesarea, Israel
Fate	Acquired by Medtronic in 2018
Products	Robotic guidance systems for spine surgery

Mazor Robotics was an Israeli medical device company that developed robotic guidance systems for spine and neurosurgical procedures, combining imaging, navigation, and mechanical guidance to assist surgeons from preoperative planning through intraoperative execution. Founded in 2001, the company became notable for systems used in minimally invasive spine surgery and was acquired by Medtronic in 2018. Its platforms were used globally across academic centers, private hospitals, and specialized clinics, influencing clinical practice, surgical training, and medical device innovation.

History

Mazor Robotics was established in 2001 in Israel by a team including Moshe Shoham and Eithan M. Galun, initially focusing on guidance technologies that integrated with imaging modalities such as computed tomography and fluoroscopy. Early collaborations involved research institutions like the Technion – Israel Institute of Technology and clinical sites including Rabin Medical Center and Sheba Medical Center. The company advanced through rounds of venture investment from firms such as OrbiMed Advisors, Vertex Venture Capital, and Pitango Venture Capital before pursuing a 2014 initial public offering on the NASDAQ under the ticker symbol MZOR. Strategic partnerships included distribution agreements with regional players and clinical alliances with academic centers like Cleveland Clinic, Mayo Clinic, and Johns Hopkins Hospital. In 2018, Medtronic announced acquisition of the company, integrating its technology into Medtronic’s spine portfolio alongside other assets from Covidien and internal platforms.

Technology and Products

Mazor Robotics developed robotic guidance platforms that combined preoperative planning software, intraoperative imaging integration, and a compact robotic arm for guidance and alignment. Its notable products included the MAZOR X system and the earlier MAZOR Renaissance system, which interfaced with imaging from Siemens Healthineers, GE Healthcare, and Philips. Software components enabled fusion of preoperative CT scan datasets with intraoperative fluoroscopy for trajectory planning used in procedures involving pedicle screw placement, spinal fusion, and deformity correction. The platforms interoperated with instrumentation from companies such as Stryker, DePuy Synthes (part of Johnson & Johnson), and Zimmer Biomet, and supported minimally invasive approaches used alongside technologies from Intuitive Surgical and navigation systems from Brainlab. The systems were designed to work with implants produced by Medtronic, NuVasive, and other implant manufacturers, and integrated with hospital information systems from vendors like Epic Systems and Cerner Corporation in perioperative workflows.

Clinical Applications

Clinical use focused on spinal procedures including lumbar fusion, cervical stabilization, thoracic instrumentation, and deformity correction. The robotics-guided platforms were applied in procedures at centers such as Massachusetts General Hospital, Mount Sinai Hospital (New York City), Vanderbilt University Medical Center, and Stanford Health Care. Surgeons used the systems for pedicle screw placement, transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF), and navigation for tumor resections in collaboration with neurosurgical teams at institutions like Mayo Clinic and UCSF Medical Center. Minimally invasive spine surgery techniques benefitted from integration with image-guidance used in centers such as Karolinska University Hospital and Royal National Orthopaedic Hospital (UK), while specialized pediatric spine programs at Great Ormond Street Hospital and Children’s Hospital of Philadelphia explored applications for scoliosis correction.

Regulatory Approvals and Safety

The company obtained regulatory clearances across multiple jurisdictions, including United States Food and Drug Administration 510(k) clearances and CE marking for use within the European Union. National regulatory bodies such as the Israeli Ministry of Health and Health Canada reviewed submissions for deployment in their markets. Safety evaluations included clinical studies and post-market surveillance coordinated with hospital institutional review boards at institutions like Cleveland Clinic and Hopital Pitie-Salpetriere. Adverse event reporting and device tracking aligned with regulations from agencies including the FDA and European Medicines Agency, and risk management followed standards such as ISO 13485 for medical device quality management systems.

Corporate Structure and Partnerships

Before acquisition, the company’s corporate governance included a board of directors with members from investment firms and clinical experts from institutions like Harvard Medical School, Weill Cornell Medicine, and Tel Aviv University. Strategic partnerships and collaborations involved distributors and clinical research agreements with hospitals such as Royal Adelaide Hospital and networks including HCA Healthcare. Technology collaborations included imaging and navigation vendors Siemens Healthineers, Philips, and GE Healthcare, while supply-chain and implant interoperability included partners Stryker, DePuy Synthes, and Zimmer Biomet. Post-acquisition integration placed assets within Medtronic’s Surgical Technologies group, aligning with Medtronic’s global sales organization and clinical affairs teams in regions like North America, Europe, and Asia Pacific.

Research and Outcomes Studies

Peer-reviewed clinical research on robotic guidance evaluated outcomes such as pedicle screw accuracy, operative time, radiation exposure, and complication rates in comparative studies at centers including Cleveland Clinic, Mayo Clinic, Johns Hopkins Hospital, and UCSF Medical Center. Multicenter registries and randomized trials compared robotic-assisted techniques to freehand and navigation-assisted methods in publications appearing in journals associated with societies like the North American Spine Society and American Academy of Orthopaedic Surgeons. Health economics analyses considered cost-effectiveness models used by hospital systems such as NHS England and large private networks like HCA Healthcare, while technology assessments informed adoption decisions by academic centers including Massachusetts General Hospital and Stanford Health Care.

Category:Medical robotics companies Category:Companies of Israel Category:Medical device manufacturers